MEDBOLIDE HOSTS A SCIENTIFIC PRESENTATION ON FLEPGO AND DIPOZAG AT THE NEPHROLOGY AND UROLOGY DEPARTMENT, TAM ANH HOSPITAL

INTRODUCTION TO TREATMENT SOLUTIONS FOR ERECTILE DYSFUNCTION AND PREMATURE EJACULATION

To help improve the effectiveness of treatment for male sexual health conditions, Medbolide Pharmaceutical JSC co-hosted a scientific seminar to introduce two products, Flepgo (Avanafil 100 mg) and Dipozag (Dapoxetine 30 mg), at the Nephrology and Urology Department of Tam Anh Hospital.

The program serves as a forum for specialists to stay updated on the latest medical evidence regarding erectile dysfunction (ED) and premature ejaculation (PE)—two common sexual dysfunctions in men—and to exchange clinical practice experiences with the aim of optimizing treatment outcomes and improving patients’ quality of life.

ERECTILE DYSFUNCTION AND PREMATURE EJACULATION – TWO COMMON CONDITIONS THAT REMAIN UNDERTREATED

According to numerous epidemiological studies, erectile dysfunction and premature ejaculation are two conditions with high prevalence rates among adult men. Not only do they affect the quality of sexual life, but these conditions also have a negative impact on patients’ mental health, family happiness, and self-confidence.

In particular, there are many cases where erectile dysfunction and premature ejaculation coexist, making treatment more complex and requiring a comprehensive, individualized treatment strategy tailored to each patient.

During the presentation, the doctors discussed modern treatment approaches, emphasizing the importance of thorough diagnosis, appropriate medication selection, and psychological counseling to enhance long-term treatment outcomes.

FLEPGO (AVANAFIL 100 MG) – A TREATMENT OPTION FOR ERECTILE DYSFUNCTION

One of the key topics of interest at the event was an update on Avanafil, a new-generation phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.

Through the Flepgo product, Medbolide presented clinical data on Avanafil, highlighting its advantages such as:

• Rapid onset of action, helping patients take a more active role in their sex lives.
• Effective in improving erectile function across various degrees of erectile dysfunction.
• High selectivity for PDE5, contributing to optimal treatment efficacy.
• Recommended by many international treatment guidelines for the management of erectile dysfunction.

In addition to reviewing the latest scientific evidence, physicians also discussed appropriate patient selection, precautions regarding drug interactions, and their experience using Avanafil in clinical practice.

DIPOZAG (DAPOXETINE 30 MG) – AN EFFECTIVE APPROACH TO THE TREATMENT OF PREMATURE EJACULATION

Alongside erectile dysfunction, premature ejaculation is also a topic of significant interest.

At the presentation, Medbolide introduced Dipozag, a product containing 30 mg of Dapoxetine—an active ingredient in the short-acting SSRI class, specifically developed for the treatment of premature ejaculation.

The technical content focused on:

• The Role of Dapoxetine in Prolonging Ejaculation.
• Improves control over ejaculation.
• Reduces stress and anxiety related to sexual activity.
• Enhances satisfaction for both the patient and their partner.

In addition, doctors also discussed diagnostic criteria for premature ejaculation based on international guidelines, selecting appropriate candidates for treatment, and important considerations during patient follow-up.

A HOLISTIC APPROACH FOR ANDROLOGY PATIENTS

A highlight of the presentation was the discussion on the relationship between erectile dysfunction and premature ejaculation.

Experts believe that thoroughly evaluating both conditions from the very first visit helps establish a comprehensive treatment plan, rather than focusing solely on a single symptom. In many cases, simultaneously managing both erectile dysfunction and premature ejaculation can lead to a more significant improvement in patients’ quality of life.

The discussion was lively, featuring many real-life clinical scenarios, and provided an opportunity for doctors to share their experiences and learn about the latest treatment approaches in the field of andrology.

MEDBOLIDE CONTINUES TO SUPPORT MEDICAL EDUCATION INITIATIVES

Through a scientific presentation program at the Nephrology and Urology Department of Tam Anh Hospital, Medbolide once again reaffirmed its commitment to supporting the medical staff in updating their evidence-based medical knowledge, thereby helping to improve the quality of patient care.

In the coming period, Medbolide will continue to roll out professional training programs, scientific seminars, and knowledge-sharing activities at hospitals nationwide, offering advanced treatment solutions with high-quality products such as Flepgo (Avanafil 100 mg) and Dipozag (Dapoxetine 30 mg), working alongside healthcare professionals to support men’s health.